Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $493.1300 (7.09%) ($493.1300 - $493.1300) on Wed. Mar. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.33% (three month average) | RSI | 75 | Latest Price | $493.1300(7.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.5% a day on average for past five trading days. | Weekly Trend | REGN advances 7.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(47%) IVW(41%) IWF(41%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -1.165% in a week (0% probabilities). VIXM(-23%) VXX(-10%) TLT(-4%) SHY(-1%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.165% (StdDev 2.33%) | Hourly BBV | 2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $459(7.44%) | 10 Day Moving Average | $444.06(11.05%) | 20 Day Moving Average | $419.64(17.51%) | To recent high | 0% | To recent low | 46.7% | Market Cap | $52.286b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |